Literature DB >> 2492956

Aneurysm associated with chronic mucocutaneous candidiasis during long-term therapy with ketoconazole.

D Leroy1, A Dompmartin, J P Houtteville, J Theron.   

Abstract

A little girl who was suffering from chronic mucocutaneous candidiasis also had a cellular immune deficiency and undetectable IgA levels. She was treated continuously for 6 years with ketoconazole at the same dosage of 200 mg/day. She was rapidly clear from infection and did not relapse although her immune abnormalities persisted. During this long-term therapy, voluminous fusiform intracranial aneurysm appeared, causing a paresis of the four limbs. Are they mycotic aneurysms?

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492956     DOI: 10.1159/000248386

Source DB:  PubMed          Journal:  Dermatologica        ISSN: 0011-9075


  7 in total

1.  Multifocal cerebral fusiform aneurysms in children with immune deficiencies report of four cases.

Authors:  J Sedat; H Alvarez; G Rodesch; P Lasjaunias
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

Review 2.  Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.

Authors:  Anne Puel; Sophie Cypowyj; László Maródi; Laurent Abel; Capucine Picard; Jean-Laurent Casanova
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-12

3.  Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.

Authors:  Anne Puel; Sophie Cypowyj; Jacinta Bustamante; Jill F Wright; Luyan Liu; Hye Kyung Lim; Mélanie Migaud; Laura Israel; Maya Chrabieh; Magali Audry; Matthew Gumbleton; Antoine Toulon; Christine Bodemer; Jamila El-Baghdadi; Matthew Whitters; Theresa Paradis; Jonathan Brooks; Mary Collins; Neil M Wolfman; Saleh Al-Muhsen; Miguel Galicchio; Laurent Abel; Capucine Picard; Jean-Laurent Casanova
Journal:  Science       Date:  2011-02-24       Impact factor: 47.728

4.  A STAT1-gain-of-function mutation causing Th17 deficiency with chronic mucocutaneous candidiasis, psoriasiform hyperkeratosis and dermatophytosis.

Authors:  Jakob Nielsen; Emil Kofod-Olsen; Eva Spaun; Carsten S Larsen; Mette Christiansen; Trine Hyrup Mogensen
Journal:  BMJ Case Rep       Date:  2015-10-22

Review 5.  Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.

Authors:  Satoshi Okada; Takaki Asano; Kunihiko Moriya; Stephanie Boisson-Dupuis; Masao Kobayashi; Jean-Laurent Casanova; Anne Puel
Journal:  J Clin Immunol       Date:  2020-08-27       Impact factor: 8.317

6.  Intracranial aneurysm associated with chronic mucocutaneous candidiasis.

Authors:  M G Marazzi; E Bondi; A Giannattasio; M Strozzi; C Savioli
Journal:  Eur J Pediatr       Date:  2007-04-19       Impact factor: 3.183

7.  An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis.

Authors:  Bertrand Boisson; Chenhui Wang; Vincent Pedergnana; Ling Wu; Sophie Cypowyj; Michel Rybojad; Aziz Belkadi; Capucine Picard; Laurent Abel; Claire Fieschi; Anne Puel; Xiaoxia Li; Jean-Laurent Casanova
Journal:  Immunity       Date:  2013-10-10       Impact factor: 31.745

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.